These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23646961)

  • 1. The puzzle(s) of pharmacoresistant epilepsy.
    Pohlmann-Eden B; Weaver DF
    Epilepsia; 2013 May; 54 Suppl 2():1-4. PubMed ID: 23646961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s).
    Weaver DF; Pohlmann-Eden B
    Epilepsia; 2013 May; 54 Suppl 2():80-5. PubMed ID: 23646978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoresistance in epilepsy. Proceedings of the 2nd Halifax International Epilepsy Conference & Retreat. September 21–22, 2012. Halifax, Nova Scotia, Canada.
    Epilepsia; 2013 May; 54 Suppl 2():1-85. PubMed ID: 23866338
    [No Abstract]   [Full Text] [Related]  

  • 5. Impaired mitochondrial energy production: the basis of pharmacoresistance in epilepsy.
    Yuen AW; Sander JW
    Med Hypotheses; 2011 Oct; 77(4):536-40. PubMed ID: 21737204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-resistant epilepsy].
    Nakken KO; Taubøll E
    Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The methylation hypothesis of pharmacoresistance in epilepsy.
    Kobow K; El-Osta A; Blümcke I
    Epilepsia; 2013 May; 54 Suppl 2():41-7. PubMed ID: 23646970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern antiepileptic drugs: guidelines and beyond.
    Hitiris N; Brodie MJ
    Curr Opin Neurol; 2006 Apr; 19(2):175-80. PubMed ID: 16538093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy.
    Pohlmann-Eden B; Crocker CE; Schmidt MH
    Epilepsia; 2013 May; 54 Suppl 2():75-9. PubMed ID: 23646977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting pharmacoresistance in pediatric epilepsy.
    Wirrell EC
    Epilepsia; 2013 May; 54 Suppl 2():19-22. PubMed ID: 23646966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary of the Eleventh Eilat Conference on New Antiepileptic Drugs and inauguration of editors' choice open access articles in epilepsy research.
    Treiman DM
    Epilepsy Res; 2013 Jan; 103(1):1. PubMed ID: 23265715
    [No Abstract]   [Full Text] [Related]  

  • 12. Design of innovative therapeutics for pharmacoresistant epilepsy: challenges and needs.
    Weaver DF
    Epilepsia; 2013 May; 54 Suppl 2():56-9. PubMed ID: 23646972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drug treatment 2011; current limitations and future perspectives.
    Boon PA
    Seizure; 2011 Jun; 20(5):357-8. PubMed ID: 21498088
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to antiepileptic drug therapy: winners and losers.
    Brodie MJ
    Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of epilepsy: new armamentarium, new issues.
    Vajda FJ
    J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
    Pati S; Alexopoulos AV
    Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
    Remy S; Beck H
    Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
    Herranz JL
    Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative clinical trial designs for future antiepileptic drugs.
    Dichter MA
    Epilepsia; 2007; 48 Suppl 1():26-30. PubMed ID: 17316410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.